Sex differences in disease progression in Alzheimer patients with different concomitant medications.
Objectives: To examine potential sex differences in cognitive and functional progression rates in Alzheimer’s disease (AD) between patients with different concomitant medications. Methods: The Swedish Alzheimer Treatment Study is a prospective, observational, multicentre study in clinical practice undertaken at the initiation of cholinesterase inhibitor therapy in 1,021 patients diagnosed with mil